Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Vera Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +13 vs. Q4 2021
- Shares held
- 19.7M
- +5.62M (+40.0%) vs. Q4 2021
- Total value
- $468.9M
- +$94.0M (+25.1%) vs. Q4 2021
- New holders
- 15
- 23 more added
- Sold out
- 2
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 4,012,030 | $94.2M | 0.01% | +866,828+27.6% | Added |
| Sofinnova Investments, Inc. | 3,181,442 | $74.7M | 6.28% | +266,666+9.1% | Added |
| Abingworth LLP | 2,960,231 | $69.3M | 19.66% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,089,520 | $49.1M | 0.06% | +356,338+20.6% | Added |
| Ra Capital Management, L.P. | 1,966,084 | $46.2M | 1.01% | +1,966,084 | New |
| BlackRock Inc. | 679,675 | $16.0M | 0.00% | +224,575+49.3% | Added |
| Vivo Capital, LLC | 666,666 | $15.7M | 1.08% | +666,666 | New |
| Vanguard Group Inc | 618,003 | $14.5M | 0.00% | +229,025+58.9% | Added |
| Octagon Capital Advisors LP | 575,000 | $13.5M | 2.92% | −95,940−14.3% | Reduced |
| Kynam Capital Management, LP | 502,328 | $11.8M | 3.84% | +248,879+98.2% | Added |
| International Biotechnology Trust PLC | 190,749 | $11.6M | 5.10% | +70,214+58.3% | Added |
| Logos Global Management LP | 385,000 | $9.04M | 1.17% | +335,000+670.0% | Added |
| Baker Bros. Advisors LP | 333,333 | $7.83M | 0.04% | +333,333 | New |
| Alphabet Inc. | 301,580 | $7.08M | 0.23% | −412,078−57.7% | Reduced |
| Geode Capital Management, LLC | 202,547 | $4.76M | 0.00% | +80,965+66.6% | Added |
| State Street Corp | 168,757 | $3.96M | 0.00% | +45,484+36.9% | Added |
| JPMorgan Chase & Co | 149,601 | $3.51M | 0.00% | +73,475+96.5% | Added |
| Millennium Management LLC | 133,500 | $3.14M | 0.00% | +133,500 | New |
| Northern Trust Corp | 109,407 | $2.57M | 0.00% | +31,554+40.5% | Added |
| Maven Securities LTD | 64,240 | $1.51M | 0.31% | +64,240 | New |
| Polar Asset Management Partners Inc. | 60,000 | $1.41M | 0.02% | +60,000 | New |
| Bank of New York Mellon Corp | 48,836 | $1.15M | 0.00% | +28,247+137.2% | Added |
| Nuveen Asset Management, LLC | 53,623 | $1.14M | 0.00% | +38,525+255.2% | Added |
| Charles Schwab Investment Management Inc | 34,743 | $817.0K | 0.00% | +11,251+47.9% | Added |
| Morgan Stanley | 18,518 | $435.0K | 0.00% | −8,173−30.6% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $419.0K | 0.00% | 00.0% | Unchanged |
| Gyon Technologies Capital Management, LP | 16,961 | $398.0K | 0.28% | −7,592−30.9% | Reduced |
| Carnegie Mellon University | 16,060 | $377.0K | 0.16% | −16,060−50.0% | Reduced |
| Bank of America Corp | 15,604 | $367.0K | 0.00% | +3,697+31.0% | Added |
| Ensign Peak Advisors, Inc | 13,277 | $312.0K | 0.00% | +13,277 | New |
| New York State Common Retirement Fund | 10,983 | $258.0K | 0.00% | +4,434+67.7% | Added |
| Citigroup Inc | 10,895 | $256.0K | 0.00% | +8,238+310.0% | Added |
| Rhumbline Advisers | 10,385 | $244.0K | 0.00% | +10,385 | New |
| Cambridge Trust Co | 9,887 | $232.0K | 0.01% | 00.0% | Unchanged |
| MetLife Investment Management | 8,881 | $208.6K | 0.00% | +8,881 | New |
| Deutsche Bank AG | 8,104 | $191.0K | 0.00% | +2,091+34.8% | Added |
| American International Group, Inc. | 6,794 | $160.0K | 0.00% | +1,535+29.2% | Added |
| California State Teachers Retirement System | 5,850 | $137.0K | 0.00% | +434+8.0% | Added |
| Wells Fargo & Company | 2,955 | $69.0K | 0.00% | −2,742−48.1% | Reduced |
| Barclays PLC | 2,222 | $53.0K | 0.00% | +2,222 | New |
| UBS Group AG | 2,009 | $47.0K | 0.00% | +2,009 | New |
| STRS Ohio | 1,600 | $37.0K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,438 | $34.0K | 0.00% | +1,438 | New |
| Amalgamated Financial Corp. | 1,438 | $34.0K | 0.00% | +1,438 | New |
| Royal Bank of Canada | 1,341 | $32.0K | 0.00% | −1,355−50.3% | Reduced |
| Legal & General Group Plc | 1,307 | $31.0K | 0.00% | +374+40.1% | Added |
| Ameritas Investment Partners, Inc. | 1,061 | $25.0K | 0.00% | +519+95.8% | Added |
| Metropolitan Life Insurance Co | 1,041 | $24.5K | 0.00% | +1,041 | New |
| US Bancorp | 1,000 | $23.0K | 0.00% | +1,000 | New |
| Tower Research Capital LLC (TRC) | 227 | $5.00K | 0.00% | −311−57.8% | Reduced |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −21,555−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −8,287−100.0% | Sold out |